Prognostic significance of lymphocyte-activation gene-3 expression in chemoradiotherapy-naive esophageal and gastric adenocarcinoma

被引：0
|
作者：
Siesing, C. [1 ]
Svensson, M. C. [1 ]
Hedner, C. [1 ]
Nodin, B. [1 ]
Borg, D. [1 ]
Jirstrom, K. [1 ]
机构：
[1] Lund Univ, Fac Med, Dept Clin Sci Oncol & Pathol, Lund, Sweden
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
基金：
瑞典研究理事会;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
655P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prognostic impact of lymphocyte-Activation Gene-3 (LAG-3) expression in triple negative breast cancer
    Kim, Ji-Yeon
    Kim, Jeehyun
    Jung, Hae Hyun
    Cho, Eun Yoon
    Park, Yeon Hee
    Ahn, Jin Seok
    Kim, Kyoung-Mee
    Im, Young-Hyuck
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [2] Lymphocyte-activation gene-3, an important immune checkpoint in cancer
    He, Yayi
    Rivard, Christopher J.
    Rozeboom, Leslie
    Yu, Hui
    Ellison, Kim
    Kowalewski, Ashley
    Zhou, Caicun
    Hirsch, Fred R.
    [J]. CANCER SCIENCE, 2016, 107 (09): : 1193 - 1197
  • [3] Pattern of p53 protein expression is predictive for survival in chemoradiotherapy-naive esophageal adenocarcinoma
    Ten Kate, Fiebo J. C.
    Suzuki, Lucia
    Dorssers, Lambert C. J.
    Dinjens, Winand N. M.
    Jones, David T. W.
    Nieboer, Daan
    Doukas, Michael
    Van Lanschot, J. Jan B.
    Wijnhoven, Bas P. L.
    Looijenga, Leendert H. J.
    Biermann, Katharina
    [J]. ONCOTARGET, 2017, 8 (61) : 104123 - 104135
  • [4] Prognostic Value of Lymphocyte Activation Gene-3 (LAG-3) Expression in Esophageal Squamous Cell Carcinoma
    Zhang, Yu
    Liu, Yong-dong
    Luo, Yi-ling
    Liu, Bin-liu
    Huang, Qi-tao
    Wang, Fang
    Zhong, Qian
    [J]. JOURNAL OF CANCER, 2018, 9 (22): : 4287 - 4293
  • [5] Lymphocyte-Activation Gene-3 Expression and Prognostic Value in Neoadjuvant-Treated Triple-Negative Breast Cancer
    Wang, Yunxuan
    Dong, Tieying
    Xuan, Qijia
    Zhao, Hong
    Qin, Ling
    Zhang, Qingyuan
    [J]. JOURNAL OF BREAST CANCER, 2018, 21 (02) : 124 - 133
  • [6] Prognostic significance of lymphocyte activation gene-3 (LAG3 gene) in uveal melanoma patients
    Singh, L.
    Singh, M. K.
    Kumar, N.
    Jha, J.
    Lomi, N.
    Sen, S.
    Kashyap, S.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1463 - S1464
  • [7] Expression of PD-L1 and PD-1 in Chemoradiotherapy-Naive Esophageal and Gastric Adenocarcinoma: Relationship With Mismatch Repair Status and Survival
    Svensson, Maria C.
    Borg, David
    Zhang, Cheng
    Hedner, Charloffa
    Nodin, Bjorn
    Uhlen, Mathias
    Mardinoglu, Add
    Leandersson, Karin
    Jirstrom, Karin
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9
  • [8] Associations of PD-1 and PD-L1 expression with mismatch repair status and prognosis in chemoradiotherapy-naive esophageal and gastric adenocarcinoma.
    Svensson, Maria
    Borg, David
    Zhang, Cheng
    Hedner, Charlotta
    Nodin, Bjorn
    Uhlen, Mathias
    Mardinoglu, Adil
    Leandersson, Karin
    Jirstrom, Karin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [9] PD-L1 expression in primary tumours and paired lymph node metastases in chemoradiotherapy-naive esophageal and gastric adenocarcinoma: Relationship with MSI status and prognosis
    Svensson, M.
    Borg, D.
    Hedner, C.
    Eberhard, J.
    Nodin, B.
    Leandersson, K.
    Jirstrom, K.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [10] Epstein-Barr virus infection in chemoradiotherapy-naive gastric adenocarcinoma: relationship with PD-L1 Expression and survival
    Sassi, F.
    Jouini, R.
    Ben Lazreg, K.
    Helal, I.
    Khanchel, F.
    Hedhli, R.
    Zaafouri, H.
    Sabbah, M.
    Khayat, O.
    Ben Brahim, E.
    Chadli, A.
    [J]. VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S93 - S93
12345